- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
HALEON PLC (HLN)
Assess today's latest current Haleon (HLN) share price, performance and insights using our live LON: HLN stock exchange data.
Haleon plc (HLN) is a well-known multinational company in the consumer healthcare industry, headquartered in Weybridge, England. It holds a significant position as the second largest consumer healthcare business globally. The company boasts a diverse portfolio of popular brands, including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. With a market share of 7.3 percent in 2022, Haleon is recognised as a global leader in over-the-counter medicines.
Analyse historical data and Haleon share price performance charts on this page. Our technical summary section provides analysis on Haleon stock price buy/sell indicators using real-time data (or discuss the Haleon (HLN) share price with other investors in the share price and sentiment chat forum). Use the dropdown to select a relevant stock exchange for the current NASDAQ: HLN stock or LON: HLN share price (ISIN: GB00BMX86B70) to enhance your trading decisions with our free resources.
Haleon plc (HLN) is a well-known multinational company in the consumer healthcare industry, headquartered in Weybridge, England. It holds a significant position as the second largest consumer healthcare business globally. The company boasts a diverse portfolio of popular brands, including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. With a market share of 7.3 percent in 2022, Haleon is recognised as a global leader in over-the-counter medicines.
Analyse historical data and Haleon share price performance charts on this page. Our technical summary section provides analysis on Haleon stock price buy/sell indicators using real-time data (or discuss the Haleon (HLN) share price with other investors in the share price and sentiment chat forum). Use the dropdown to select a relevant stock exchange for the current NASDAQ: HLN stock or LON: HLN share price (ISIN: GB00BMX86B70) to enhance your trading decisions with our free resources.
372.90
+11.80(+3.27%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
353.60
372.90
52 wk Range
325.10
419.40
HLN is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
353.60372.90
52 wk Range
325.10419.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.88%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.88%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
HLN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
417.75
Upside
+12.03%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 3 consecutive years
- Form 6K HALEON PLC ADR For: 6 January
- Investing.com
- HALEON receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- HALEON receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
HALEON Company Profile
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Compare HLN to Peers and Sector
Metrics to compare | HLN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHLNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 21.1x | 21.9x | −0.6x | |
PEG Ratio | 0.52 | 0.31 | 0.00 | |
Price/Book | 2.0x | 3.0x | 2.6x | |
Price / LTM Sales | 2.9x | 2.3x | 3.4x | |
Upside (Analyst Target) | 15.5% | 10.4% | 41.5% | |
Fair Value Upside | Unlock | 12.8% | 5.5% | Unlock |
Analyst Ratings
10 Buy
5 Hold
2 Sell
Ratings:
17 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 417.75
(+12.03% Upside)
Earnings
Latest Release
Oct 30, 2025
EPS / Forecast
0.0457 / 0.0494
Revenue / Forecast
2.80B / 2.77B
People Also Watch
FAQ
What Is the HALEON (HLN) Share Price Today?
The live HALEON share price today is 372.90
What Stock Exchange Does HALEON (HLN) Trade On?
HALEON is listed and trades on the London Stock Exchange.
What Is the Ticker (Stock Symbol) for HALEON?
The stock symbol (also called a 'ticker') for HALEON is "HLN."
Does HALEON Pay Dividends? What’s The Current HLN Dividend Yield?
Yes, HLN Pays Dividends to its Shareholders. The current HALEON dividend yield is 1.88%.
What Is the Current HALEON Market Cap?
As of today, HALEON market capitalisation is 32.16B.
What Is HALEON's (HLN) Earnings Per Share (TTM)?
The HALEON EPS is currently 0.17 (Trailing Twelve Months).
When Is the Next HALEON Earnings Date?
HALEON's next earnings report will be released on 25 Feb 2026.
Is HLN a Buy or Sell From a Technical Analyst Perspective?
Based on today's HALEON moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has HALEON Stock Split?
HALEON has split 0 times. (See the HLN stock split history page for full effective split date and price information.)
How Many Employees Does HALEON Have?
HALEON has 24561 employees.
What is the current trading status of HALEON (HLN)?
As of 20 Jan 2026, HALEON (HLN) is trading at a price of 372.90, with a previous close of 361.10. The stock has fluctuated within a day range of 353.60 to 372.90, while its 52-week range spans from 325.10 to 419.40.
What Is HALEON (HLN) Price Target According to Analysts?
The average 12-month price target for HALEON is GBP417.75, with a high estimate of GBP517 and a low estimate of GBP335. 10 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Buy. The stock has an +12.03% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.